BackgroundTinnitus, a common auditory disorder, significantly impacts patient quality of life and lacks universally effective treatments. The integration of advanced imaging technology like ultrasound in therapeutic interventions offers new possibilities in healthcare.ObjectiveThis study evaluated the efficacy of ultrasound-guided stellate ganglion block as an innovative approach to managing tinnitus.MethodsEighty patients with tinnitus were randomly assigned to either a control group receiving standard drug therapy or an observation group treated with ultrasound-guided stellate ganglion block in addition to standard therapy. Key metrics, including clinical effectiveness rates, anxiety scores, and tinnitus disability index scores, were assessed pre- and post-treatment.ResultsPost-treatment outcomes revealed that the observation group exhibited significantly improved anxiety scores (38.74 ± 4.05 vs. 50.45 ± 4.86; P < 0.05) and tinnitus disability index scores (37.8 ± 17.56 vs. 50.4 ± 21.26; P < 0.05) compared to the control group. Additionally, the observation group achieved a 100% clinical efficacy rate, outperforming the control group's 84% (P < 0.05).ConclusionUltrasound-guided stellate ganglion block demonstrates superior efficacy in managing tinnitus compared to conventional drug therapy. This study underscores the potential of integrating advanced ultrasound technology into healthcare to optimize treatment outcomes for auditory disorders.